SpecImmune accurately genotypes diverse immune-related gene families using long-read data

preprint OA: closed
📄 Open PDF Full text JSON View at publisher

Abstract

ABSTRACT Polymorphic immune-related genes (HLA, KIR, IG, TCR, and CYP) exhibit significant complexity due to their extensive heterozygosity and inter-loci homology, necessitating specific methods for accurate characterization. We present SpecImmune, the first comprehensive tool leveraging long-read sequencing data to resolve the full spectrum of these immune-related genes. The method adopts an iterative graph-based algorithm for haplotype reconstruction. We validated SpecImmune across 1,019 samples from the 1kGP ONT cohort, 42 PacBio CLR and 9 PacBio HiFi samples from the HGSVC project, and 47 PacBio HiFi and 37 ONT samples from the HPRC project. SpecImmune achieved an accuracy of 98% in HLA typing, which represents a 12% improvement over both SpecHLA and HLA*LA. SpecImmune is the initial method to type multiple CYP loci, as well as the foremost approach to allow precise KIR and germline IG/TCR typing using long reads. Comprehensive genotyping of these loci by SpecImmune unveils a new observation of substantial linkage disequilibrium among HLA, KIR, and CYP loci. The proteins derived from these loci exhibit strong binding affinities, which suggest the origin of the marked linkage disequilibrium. Further, SpecImmune unveils a novel finding of elevated IG/TCR heterozygosity in African populations. Additionally, SpecImmune facilitates the detection of de novo mutations and enables allele-specific drug recommendations.
Full text 1,516 characters · extracted from oa-doi-fallback · click to expand
ABSTRACT Polymorphic immune-related genes (HLA, KIR, IG, TCR, and CYP) exhibit significant complexity due to their extensive heterozygosity and inter-loci homology, necessitating specific methods for accurate characterization. We present SpecImmune, the first comprehensive tool leveraging long-read sequencing data to resolve the full spectrum of these immune-related genes. The method adopts an iterative graph-based algorithm for haplotype reconstruction. We validated SpecImmune across 1,019 samples from the 1kGP ONT cohort, 42 PacBio CLR and 9 PacBio HiFi samples from the HGSVC project, and 47 PacBio HiFi and 37 ONT samples from the HPRC project. SpecImmune achieved an accuracy of 98% in HLA typing, which represents a 12% improvement over both SpecHLA and HLA*LA. SpecImmune is the initial method to type multiple CYP loci, as well as the foremost approach to allow precise KIR and germline IG/TCR typing using long reads. Comprehensive genotyping of these loci by SpecImmune unveils a new observation of substantial linkage disequilibrium among HLA, KIR, and CYP loci. The proteins derived from these loci exhibit strong binding affinities, which suggest the origin of the marked linkage disequilibrium. Further, SpecImmune unveils a novel finding of elevated IG/TCR heterozygosity in African populations. Additionally, SpecImmune facilitates the detection of de novo mutations and enables allele-specific drug recommendations. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00